Only one week after the household of Henrietta Lacks reached a historic settlement with a biotech firm over its use of Lacks’ cells of their merchandise, the property is suing a second firm for unjustly profiting off of her genetics.
The lawsuit, filed on Thursday in the USA District Courtroom for the District of Maryland, is towards Novato, California-based Ultragenyx — a biopharmaceutical company “targeted on growing first-ever accredited therapies for uncommon and ultrarare ailments.”
The $2.6 billion firm is being sued for utilizing Lacks’ cell line to provide adeno-associated virus vector-based gene remedy merchandise with out looking for consent from or compensating her household.
Lawyer Benjamin Crump, who’s representing the Lacks property alongside Seeger Weiss companions Chris Seeger and Chris Ayers, says the corporate is working towards medical racism.
“Ultragenyx’s option to proceed using HeLa cells regardless of the cell line’s origin and the concrete hurt it inflicts on the Lacks household can solely be understood as a option to embrace a legacy of racial injustice embedded within the U.S. analysis and medical programs,” he mentioned in an announcement.
“Like anybody else, Black folks have the precise to regulate their our bodies. Simply as Ultragenyx takes benefit of Henrietta Lacks’ immortal cell line, in addition they reap the benefits of susceptible people with uncommon sicknesses by value gouging them for important therapies.”
In response to the authorized group, Ultragenyx is conscious of the “unethical origins” of the immortal HeLa cell line, stolen from Lacks’ physique by medical doctors with out her data or consent.
She was a cervical most cancers affected person at Johns Hopkins Hospital when the 1951 assault occurred. In a racially segregated ward, medical doctors surgically extracted tissue samples and cultivated them into the primary immortal human cell line.
Our lawsuit goals to assist the Lacks household reclaim their ancestor’s story and obtain the justice and compensation they deserve.
Chris SeegeR, Lawyer
Since her demise in 1951, her cell line has been utilized in numerous medical advances, from the examine of AIDS to the event of the COVID-19 vaccines. She and her household, nevertheless, have obtained little recognition.
It wasn’t till just lately that Lacks’ household noticed some justice after profitable a settlement towards Thermo Fisher Scientific, a $217 billion firm.
Ayers introduced at a latest press convention that extra corporations could be up subsequent. Ultragenyx is simply the newest to be held accountable.
“Ultragenyx’s resolution to revenue from Henrietta Lacks’s cells with out permission from her household is a evident instance of a biotech firm violating moral boundaries for monetary achieve,” Ayers mentioned in an announcement.
“Ultragenyx understands—certainly, acknowledges by itself web site—that the HeLa cells it cultivates for revenue at present had been stolen from Mrs. Lacks. The corporate’s enterprise is nothing greater than a perpetuation of this theft.”
Seeger says it’s time for Lacks’ legacy to vary.
“The enduring legacy of Henrietta Lacks needs to be one in all acknowledgment, respect, and restitution, not continued exploitation by corporations like Ultragenyx,” he mentioned in an announcement. “Their actions stand as a grim reminder of America’s historical past of medical racism and the pressing must rectify these previous wrongs. Our lawsuit goals to assist the Lacks household reclaim their ancestor’s story and obtain the justice and compensation they deserve.”
Get Phrase In Black straight in your inbox. Subscribe at present.
